Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mesoporous Biomaterial Could Provide Relief for Sensitive Teeth

By HospiMedica International staff writers
Posted on 19 Jan 2015
A new biomaterial based on silica can potentially rebuild worn enamel and reduce tooth sensitivity for an extended period.

Developed by researchers at National Taiwan University (NTU; Taipei), the gelatin-template, mesoporous silica biomaterial contains nanosized calcium carbonate particles mixed with 30% H3PO4 at a 1:1 molar ratio of calcium to phosphate (CCMS-HP). More...
In experiments conducted in dogs, the combination enabled the calcium and phosphate ions created to permeate the dentinal tubules and form dicalcium phosphate dihydrate (DCPD), tricalcium phosphate (TCP), and hydroxyapatite (HAp) crystals at a depth of approximately 40 μm.

This increased depth could be the key, according to the researchers, to repairing damaged enamel and providing longer-lasting relief from tooth sensitivity than current tubuli sealants. Alkaline phosphatase assays and biocompatibility tests showed high cell viability and mineralization ability. In vivo efficacy and biocompatibility analyses of the biomaterial in the animal model revealed significant DCPD, TCP, and HAp crystal growth and no pulp irritation after 70 days. The study was published in the December 2014 issue of ACS Nano.

“The developed CCMS-HP holds great promise for treating exposed dentin by growing biomimetic crystals within dentinal tubules,” concluded lead author, Prof. Chun-Pin Lin, DDS, dean of the NTU school of dentistry, and colleagues. “These findings demonstrate that the mesoporous silica biomaterials presented here have great potential for serving as both a catalyst and carrier in the repair or regeneration of dental hard tissue.”

Mesoporous silica is a form of silica that contains nanometric spheres or rods arranged in a regular pattern of pores. The large surface area of the pores allows the particles to be filled with a drug or other particles that can be taken up by certain biological cells through endocytosis, depending on what chemicals are attached to the outside of the spheres, as well as boosting the in vitro and in vivo dissolution of poorly water soluble drugs.

Related Links:

National Taiwan University



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.